Future Perspectives of Gene Therapy for Gastric Cancer

  • Yoshio Miki


The last two decades have led to a greater understanding of the genetic basis of human malignancy. Although many genetic alterations have been detected in cancer, the activation of oncogenes and inactivation of tumor-suppressor genes are known to play a significant role in the progression of cancer.


Gastric Cancer Gene Therapy Proliferate Cell Nuclear Antigen Gastric Cancer Cell Line Suicide Gene 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Uckert W, Walther W (1994) Retrovirus-mediated gene transfer in cancer therapy. Pharmacol Ther 63:323–347PubMedCrossRefGoogle Scholar
  2. 2.
    Horwitz MS (1990) Adenoviridae and their replication. In: Field BN, Knipe DM, Chanock RM, Melnick JL, Hirsch MS, Monath TP, Roizman BS (eds) Virology. Raven, New York, pp 1679–1729Google Scholar
  3. 3.
    Yam P, Chow W, Zaia JA, Yee JK (1995) Comparison of pseudo-type and aphotropic retro viral mediated gene transfer into human hematopoietic progenitors and cell line. Cancer Gene Ther 2:323Google Scholar
  4. 4.
    Naldini L, Blomer U, Gallay P, Ory D, Mulligan R, Gage FH, Verma IM, Trono D (1996) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272:263–267PubMedCrossRefGoogle Scholar
  5. 5.
    Ledley FD (1995) Nonviral gene therapy: the promise of genes as pharmaceutical products. Hum Gene Ther 6:1129–1144PubMedCrossRefGoogle Scholar
  6. 6.
    Nabel GJ, Nabel EG, Yang ZY, Fox BA, Plautz GE, Gao X, Huang L, Shu S, Gordon D, Chang AE (1993) Direct gene transfer with DNA-liposome complexes in melanoma: expression, biologic activity, and lack of toxicity in humans. Proc Natl Acad Sci USA 90:11307–11311PubMedCrossRefGoogle Scholar
  7. 7.
    Cheng L, Ziegelhoffer PR, Yang NS (1993) In vivo promoter activity and transgene expression in mammalian somatic tissues evaluated by using particle bombardment. Proc Natl Acad Sci USA 90:4455–4459PubMedCrossRefGoogle Scholar
  8. 8.
    Nabel EG, Gordon D, Yang ZY, Xu L, San H, Plautz GE, Wu BY, Gao X, Huang L, Nabel GJ (1992) Gene transfer in vivo with DNA-liposome complexes: lack of autoimmunity and gonadal localization. Hum Gene Ther 3:649–656PubMedCrossRefGoogle Scholar
  9. 9.
    Fearon ER, Pardoll DM, Itaya T, Golumbek P, Levitsky HI, Simons JW, Karasuyama H, Vogelstein B, Frost P (1990) Interleukin-2 production by tumor cells bypasses T helper function in the generation of an antitumor response. Cell 60:397–403PubMedCrossRefGoogle Scholar
  10. 10.
    Gansbacher B, Bannerji R, Daniels B, Zier K, Cronin K, Gilboa E (1990) Retroviral vector-mediated gamma-interferon gene transfer into tumor cells generates potent and long lasting antitumor immunity. Cancer Res 50:7820–7825PubMedGoogle Scholar
  11. 11.
    Zier KS, Gansbacher B (1995) The impact of gene therapy on T cell function in cancer. Hum Gene Ther 6:1259–1264PubMedCrossRefGoogle Scholar
  12. 12.
    Pardoll D (1992) Immunotherapy with cytokine gene-transduced tumor cells: the next wave in gene therapy for cancer. Curr Opin Oncol 4:1124–1129PubMedCrossRefGoogle Scholar
  13. 13.
    Salvadori S, Gansbacher B, Wernick I, Tirelli S, Zier K (1995) B7-1 amplifies the response to interleukin-2-secreting tumor vaccines in vivo, but fails to induce a response by naive cells in vitro. Hum Gene Ther 6:1299–1306PubMedCrossRefGoogle Scholar
  14. 14.
    Tepper RI, Mule JJ (1994) Experimental and clinical studies of cytokine gene-modified tumor cells. Hum Gene Ther 5:153–164PubMedCrossRefGoogle Scholar
  15. 15.
    Moolten FL, Wells JM (1990) Curability of tumors bearing herpes thymidine kinase genes transferred by retroviral vectors. J Natl Cancer Inst 82:297–300PubMedCrossRefGoogle Scholar
  16. 16.
    Plautz G, Nabel EG, Nabel GJ (1991) Selective elimination of recombinant genes in vivo with a suicide retroviral vector. New Biol 3:709–715PubMedGoogle Scholar
  17. 17.
    Mesnil M, Piccoli C, Tiraby G, Willecke K, Yamasaki H (1996) Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins. Proc Natl Acad Sci USA 93:1831–1835PubMedCrossRefGoogle Scholar
  18. 18.
    Culver KW, Ram Z, Wallbridge S, Ishii H, Oldfield EH, Blaese RM (1992) In vivo gene transfer with retroviral vector-producer cells for treatment fo experimental brain tumors. Science 256:1550–1552PubMedCrossRefGoogle Scholar
  19. 19.
    Marcel T (1995) The RAC and world wide gene therapy report. TMC Development, ParisGoogle Scholar
  20. 20.
    Caruso M, Panis Y, Gagandeep S, Houssin D, Salzmann JL, Klatzmann D (1993) Regression of established macroscopic liver metastases after in situ transduction of a suicide gene. Proc Natl Acad Sci USA 90:7024–7028PubMedCrossRefGoogle Scholar
  21. 21.
    Bishop JM (1991) Molecular themes in oncogenesis. Cell 64:235–248PubMedCrossRefGoogle Scholar
  22. 22.
    Cohen JS (1994) Gene-mimetic substances: drugs designed to intervene in gene expression. Adv Pharmacol 25:319–339PubMedCrossRefGoogle Scholar
  23. 23.
    Ohta Y, Tone T, Shitara T, Funato T, Jiao L, Kashfian BI, Yoshida E, Horng M, Tsai P, Lauterbach K (1994) H-ras ribozyme-mediated alteration of the human melanoma phenotype. Ann NY Acad Sei 716:242–53CrossRefGoogle Scholar
  24. 24.
    Friedmann T (1992) Gene therapy of cancer through restoration of tumor-suppressor functions? Cancer 70:1810–1817PubMedCrossRefGoogle Scholar
  25. 25.
    Hollingsworth RE, Lee WH (1991) Tumor suppressor genes: new prospects for cancer research. J Natl Cancer Inst 83:91–96PubMedCrossRefGoogle Scholar
  26. 26.
    Harris CC (1996) Structure and function of the p53 tumor suppressor gene: clues for rational cancer therapeutic strategies. J Natl Cancer Inst 88:1442–1455PubMedCrossRefGoogle Scholar
  27. 27.
    Dameron KM, Volpert OV, Tainsky MA, Bouck N (1994) Control of angiogenesis in fibroblasts by p53 regulation of thrombospondin-1. Scinece 265:1582–1584CrossRefGoogle Scholar
  28. 28.
    Baker SJ, Markowitz S, Fearon ER, Willson JK, Vogelstein B (1990) Suppression of human colorectal carcinoma cell growth by wild-type p53. Science 249:912–915PubMedCrossRefGoogle Scholar
  29. 29.
    Mulligan LM, Matlashewski GJ, Scrable HJ, Cavenee WK (1990) Mechanisms of p53 loss in human sarcomas. Proc Natl Acad Sci USA 87:5863–5867PubMedCrossRefGoogle Scholar
  30. 30.
    Roth JA, Nguyen D, Lawrence DD, Kemp BL, Carrasco CH, Ferson DZ, Hong WK, Komaki R, Lee JJ, Nesbitt JC, Pisters Km, Putnam JB, Schea R, Shin DM, Walsh GL, Dolormente MM, Han CI, Martin FD, Yen N, Xu K, Stephens LC, McDonnell TJ, Mukhopadhyay T, Cai D (1996) Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer. Nat Med 2:985–991PubMedCrossRefGoogle Scholar
  31. 31.
    Flasshove M, Banerjee D, Bertino JR, Moore MA (1995) Increased resistance to methotrexate in human hematopoietic cells after gene transfer of the Ser31 DHFR mutant. Leukemia 9:S34–37PubMedGoogle Scholar
  32. 32.
    Allay JA, Dumenco LL, Koc ON, Liu L, Gerson SL (1995) Retroviral transduction and expression of the human alkyltransferase cDNA provides nitrosourea resistance to hematopoietic cells. Blood 85:3342–3351PubMedGoogle Scholar
  33. 33.
    Blaese RM, Culver KW, Anderson WF (1990) The ADA human gene therapy clinical protocol. Hum Gene Ther 1:327–362CrossRefGoogle Scholar
  34. 34.
    Tanaka T, Kanai F, Lan KH, Ohashi M, Shiratori Y, Yoshida Y, Hamada H, Omata M (1997) Adenovirus-mediated gene therapy of gastric carcinoma using cancer-specific gene expression in vivo. Biochem Biophys Res Commun 231:775–779PubMedCrossRefGoogle Scholar
  35. 35.
    Wanebo HJ, Kennedy BJ, Chmiel J, Steele G Jr, Winchester D, Osteen R (1993) Cancer of the stomach: a patient care study by the American College of Surgeons. Ann Surg 218:583–592PubMedCrossRefGoogle Scholar
  36. 36.
    Ohuchi N, Wunderlich D, Fujita J, Colcher D, Muraro R, Nose M, Schlom J (1987) Differential expression of carcinoembryonic antigen in early gastric adenocarcinomas versus benign gastric lesions defined by monoclonal antibodies reactive with restricted antigen epitopes. Cancer Res 47:3565–3571PubMedGoogle Scholar
  37. 37.
    Lan KH, Kanai F, Shiratori Y, Ohashi M, Tanaka T, Okudaira T, Yoshida Y, Hamada H, Omata M (1997) In vivo selective gene expression and therapy mediated by adenoviral vectors for human carcinoembryonic antigen-producing gastric carcinoma. Cancer Res 57:4279–4284PubMedGoogle Scholar
  38. 38.
    Yoshida K, Kawami H, Yamaguchi Y, Kuniyasu H, Nishiyama M, Hirai T, Yanagihara K, Tahara E, Toge T (1995) Retrovirally transmitted gene therapy for gastric carcinoma using herpes simplex virus thymidine kinase gene. Cancer 75:1467–1471PubMedCrossRefGoogle Scholar
  39. 39.
    Matsukura N, Onda M, Hasegawa H, Tokunaga A, Hoshino A, Igarashi T, Suzuki S, Shimada T (1997) Prospect of gene therapy for metastatic foci of gastric cancer (in Japanese). Gan To Kagaku Ryoho 24:1778–1780PubMedGoogle Scholar
  40. 40.
    Ogiso Y, Sakai N, Watari H, Yokoyama T, Kuzumaki N (1994) Suppression of various human tumor cell lines by a dominant negative H-ras mutant. Gene Ther 1:403–407PubMedGoogle Scholar
  41. 41.
    Sakakura C, Hagiwara A, Tsujimoto H, Ozaki K, Sakakibara T, Oyama T, Ogaki M, Takahashi T (1995) The anti-proliferative effect of proliferating cell nuclear antigen-specific antisense oligonucleotides on human gastric cancer cell lines. Surg Today 25:184–186PubMedCrossRefGoogle Scholar

Copyright information

© Springer Japan 1999

Authors and Affiliations

  • Yoshio Miki
    • 1
  1. 1.Department of Molecular Diagnosis, Cancer InstituteJapanese Foundation for Cancer ResearchTokyoJapan

Personalised recommendations